In this retrospective study involving CSF profiles of subjects clinically diagnosed with AD or iNPH, we found the p-tau concentrations to be significantly lower in iNPH suggesting different CSF profiles between the two groups. The gene discussed is MAPT; the disease is Alzheimer disease.